Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Acamprosate calcium
Drug ID BADD_D00017
Description Alcohol use disorder is responsible for a large worldwide burden of morbidity, premature mortality, and economic consequences resulting from accidents, violence, incarceration, decreased productivity, and increased healthcare spending.[A229073] Acamprosate, also known by the brand name Campral, is a drug used for the maintenance of alcohol abstinence. It is a structural analogue of the neurotransmitter γ-aminobutyric acid (GABA).[L31758] Acamprosate is the first medication specifically formulated for the maintenance of alcohol abstinence in ethanol-dependent patients after alcohol detoxification[A997], unlike [naltrexone] and [disulfiram]. It was first approved by the FDA in 2004 and initially marketed by Forest Laboratories.[L31783]
Indications and Usage For the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation
Marketing Status Prescription; Discontinued
ATC Code N07BB03
DrugBank ID DB00659
KEGG ID D02780
MeSH ID D000077443
PubChem ID 155434
TTD Drug ID D0GC2M
NDC Product Code 65096-0112; 60687-121; 0904-7213; 17337-0002; 68382-569; 70771-1057; 42291-104; 0093-5352; 50056-2006; 68462-435
Synonyms Acamprosate | Acamprostate | N-Acetylhomotaurine | N Acetylhomotaurine | Campral EC | N-Acetylhomotaurine, Magnesium (2:1) Salt | N-Acetylhomotaurine, Monolithium Salt | N Acetylhomotaurine, Monolithium Salt | N-Acetylhomotaurine, Zinc (2:1) Salt | Campral | N-Acetylhomotaurine, Monosodium Salt | N Acetylhomotaurine, Monosodium Salt | Sodium Acetylhomotaurine | Acetylhomotaurine, Sodium | Zulex | Acamprosate Calcium | Calcium Acetylhomotaurine | Acetylhomotaurine, Calcium | Calcium Acetylhomotaurinate | Acetylhomotaurinate, Calcium | N-Acetylhomotaurine, Calcium (2:1) Salt | Calcium Acetyl Homotaurinate | Acetyl Homotaurinate, Calcium | N-Acetylhomotaurine, Monopotassium Salt | N Acetylhomotaurine, Monopotassium Salt | Aotal | Regtect
Chemical Information
Molecular Formula C10H20CaN2O8S2
CAS Registry Number 77337-73-6
SMILES CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Lymphadenopathy01.09.01.002--Not Available
Lymphocytosis01.02.01.003--Not Available
Malaise08.01.01.003--
Mania19.16.02.002--
Melaena07.12.02.004; 24.07.02.013--Not Available
Menorrhagia21.01.03.002--
Metrorrhagia21.01.01.006--Not Available
Micturition urgency20.02.02.006--
Monocytosis01.02.01.004--Not Available
Mouth ulceration07.05.06.004--Not Available
Muscle spasms15.05.03.004--
Muscle twitching15.05.03.005--Not Available
Myalgia15.05.02.001--
Myopathy15.05.05.001--Not Available
Nausea07.01.07.001--
Neck pain15.03.04.009--
Neoplasm malignant16.16.01.001--Not Available
Nephrolithiasis20.04.01.002--
Neuralgia17.02.07.005--
Neurosis19.06.01.001--Not Available
Nocturia20.02.03.001--Not Available
Oedema peripheral02.05.04.007; 08.01.07.007; 14.05.06.011--
Oesophagitis07.08.05.001--
Pain08.01.08.004--
Pancreatitis07.18.01.001--
Panophthalmitis06.04.05.005--Not Available
Paraesthesia17.02.06.005--
Paranoia19.05.01.005--Not Available
Pharyngitis07.05.07.004; 11.01.13.003; 22.07.03.004--
Photophobia06.01.01.004; 17.17.02.006--
The 4th Page    First    Pre   4 5 6    Next   Last    Total 6 Pages